OK. Each to their own. My preference with a single shareholder looming large on the register and Board is to have 2 NEDs that are not shareholders to challenge. I think in the next 2 years there will be Pharma venture funds all over this - lets wait and see.
ARC linkage grant, page-25
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $452.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10204 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.2¢ | 25029 | 1 |
View Market Depth
| Last trade - 09.54am 05/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable